title: The conquest of melanoma by immunotherapy.
authors.affiliation: Department of Oncology, University of Lausanne, Lausanne, Switzerland.
authors.forename: Ferdy J
authors.initials: FJ
authors.lastname: Lejeune
mesh_terms: D000069594:Abatacept / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors / Q000276:immunology; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007211:Indoles / Q000627:therapeutic use; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods; D009362:Neoplasm Metastasis; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D060890:B7-H1 Antigen; C423236:CD274 protein, human; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D019496:Cancer Vaccines; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D000069594:Abatacept; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf